Last Updated : March 8, 2013
Details
FilesGeneric Name:
Everolimus
Project Status:
Complete
Therapeutic Area:
Renal angiomyolipoma associated with tuberous sclerosis complex (TSC)
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Afinitor
Project Line:
Reimbursement Review
Project Number:
SR0315-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
renal angiomyolipoma associated with tuberous sclerosis complex (TSC)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 8, 2013